Recent News

• 05.28.2025 - Alpha Tau to Present at Jefferies Global Healthcare Conference
• 05.20.2025 - Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update
• 05.13.2025 - Alpha Tau Announces Appointment of Nadav Kidron to its Board of Directors
• 05.06.2025 - Alpha Tau to Participate in May Investor Conferences
• 04.28.2025 - Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals
• 04.02.2025 - Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma

Recent Filings

• 05.28.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 05.28.2025 - EX-99.1 EX-99.1
• 05.19.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 05.19.2025 - EX-99.1 EX-99.1
• 05.13.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 05.13.2025 - EX-99.1 EX-99.1
• 05.12.2025 - EX-99.1 EX-99.1
• 05.12.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 05.06.2025 - EX-99.1 EX-99.1
• 05.06.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]